The notes are due 2029, 2036, 2043 and 2053

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of €3 billion aggregate principal amount of notes by Medtronic, Inc. Medtronic, Inc. issued €850 million aggregate principal amount of 3.650% senior notes due 2029, €850 million aggregate principal amount of 3.875% senior notes due 2036, €600 million aggregate principal amount of 4.150% senior notes due 2043 and €700 million aggregate principal amount of 4.150% senior notes due 2053, fully and unconditionally guaranteed by Medtronic plc and Medtronic Global Holdings S.C.A. Medtronic plc is the parent company of Medtronic Global Holdings S.C.A. and Medtronic Global Holdings S.C.A. is an indirect parent company of Medtronic, Inc.

Medtronic plc, headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 95,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries.

The Davis Polk corporate team included partner Deanna L. Kirkpatrick, counsel Jeffrey S. Ramsay and associate Rachel Jang. Partner Michael Mollerus and associate Ted Lee provided tax advice. The intellectual property team included partner David R. Bauer and associates Adrian Rabin and Kimberly Hickey. All members of the Davis Polk team are based in the New York office.

Copy link to share post